Read More Pharma Industry News Is Eli Lilly (LLY) building the obesity drug supply chain nobody else can easily match? Lilly’s obesity pipeline needs industrial muscle. Its $4.5bn Indiana bet shows why manufacturing may decide the next GLP-1 race. byVenkateshMay 28, 2026